(Q40466398)

20 September 2017

Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. (English)

1 reference

20 September 2017

neoplastic invasiveness

1 reference

Pillé JY

1

1 reference

20 September 2017

Denoyelle C

2

1 reference

20 September 2017

Varet J

3

1 reference

20 September 2017

Bertrand JR

4

1 reference

20 September 2017

Soria J

5

1 reference

20 September 2017

Opolon P

6

1 reference

20 September 2017

Lu H

7

1 reference

20 September 2017

Pritchard LL

8

1 reference

20 September 2017

Vannier JP

9

1 reference

20 September 2017

Malvy C

10

1 reference

20 September 2017

Soria C

11

1 reference

20 September 2017

Li H

12

1 reference

20 September 2017

1 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

11

1 reference

20 September 2017

267-274

1 reference

20 September 2017

2

1 reference

Rho signals to cell growth and apoptosis

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Rho GTPases: signaling, migration, and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Advances in Rho-dependent actin regulation and oncogenic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

7 January 2021

RHO-GTPases and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Rho GTPases are over-expressed in human tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Genomic analysis of metastasis reveals an essential role for RhoC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Membrane association and targeting of prenylated Ras-like GTPases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

The ras signaling pathway in mammary tumorigenesis and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Farnesyl transferase inhibitors as anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Inhibiting Ras signaling in the therapy of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Clinical significance of pleiotropic effects of statins: lipid reduction and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Expanding small RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

HMEC-1: establishment of an immortalized human microvascular endothelial cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.029

10.1016/J.YMTHE.2004.08.029

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference